Order results by:
| Issue | Title | |
| Vol 17, No 1 (2025) | The use of antipsychotics in the real-world clinical practice in Russia (based on the results of the EPIDEMICUS program) | Abstract similar documents |
| V. E. Medvedev | ||
| "... questionnaire, an analysis of the prescription of quetiapine and other antipsychotics by psychiatrists in 21 ..." | ||
| Vol 15, No 6 (2023) | Non-interventional epidemiological program for investigating the real-life practice of using quetiapine (Seroquel®) in patients with schizophrenia and bipolar affective disorder (EPIDEMICUS) | Abstract similar documents |
| V. E. Medvedev, I. G. Kuznetsova | ||
| "... the characteristics of the use of quetiapine (Seroquel®) in real outpatient clinical practice. Material and methods ..." | ||
| Vol 13, No 4 (2021) | Treatment of antipsychotic-induced parkinsonism in schizophrenic patients | Abstract similar documents |
| E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| "... Antipsychotic-induced parkinsonism (AIP) is one of the prognostically unfavorable complications ..." | ||
| Vol 13, No 3 (2021) | Off-label antipsychotics prescription to adolescents with acute psychotic episodes does not cause adverse drug reactions | Abstract PDF (Eng) similar documents |
| D. V. Ivashchenko, N. I. Buromskaya, A. D. Malakhova, N. A. Tsarkova, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... classes (39.6% vs. 15.43%; p=0.0001). Conclusion. Off-label antipsychotic prescription outside ..." | ||
| Vol 12, No 5 (2020) | The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study | Abstract PDF (Eng) similar documents |
| D. V. Ivashchenko, S. Z. Khoang, M. Kh. Tazagulova, B. V. Makhmudova, N. I. Buromskaya, P. V. Shimanov, R. V. Deitch, I. V. Dorina, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... taking antipsychotics. Pharmacogenetic testing allows one to more accurately choose the initial dose ..." | ||
| Vol 12, No 5 (2020) | Drug-induced dystonia | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
| "... from one antipsychotic medication to another, especially to its injectable dosage form. Tardive DID ..." | ||
| Vol 12, No 6 (2020) | The interaction of folate cycle enzyme genes and the risk of extrapyramidal side effects of antipsychotics | Abstract PDF (Eng) similar documents |
| T. V. Zhilyaeva, E. V. Akimova, A. S. Blagonravova, G. E. Mazo | ||
| "... of the key folate cycle enzymes in developing the extrapyramidal side effects of antipsychotics has not yet ..." | ||
| Vol 10, No 4 (2018) | Pharmacogenetics of schizophrenia in real clinical practice: a clinical case | Abstract similar documents |
| R. F. Nasyrova, N. A. Schnaider, K. O. Mironov, G. A. Shipulin, O. P. Dribnokhodova, E. A. Golosov, M. Yu. Tolmachev, B. V. Andreev, A. A. Kurylev, L. Sh. Akhmetova, О. V. Limankin, N. G. Neznanov | ||
| "... and financial expenditure on treatment. The basic drugs in these patients are antipsychotics that are highly ..." | ||
| Vol 5, No 1 (2013) | Bipolar affective disorders: the specific features of the course and maintenance pharmacotherapy | Abstract similar documents |
| Nina Arkadyevna Tyuvina, V N Smirnova | ||
| Vol 11, No 4 (2019) | Antipsychotic-induced tardive dyskinesia as a serious adverse effect in the psychopharmacotherapy of schizophrenia | Abstract similar documents |
| E. E. Vaiman, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| "... -aged people. Movement disorders, or extrapyramidal syndrome, are potentially reversible antipsychotic ..." | ||
| Vol 14, No 2 (2022) | Association between redox imbalance, pterin metabolism markers, and early extrapyramidal side effects of antipsychotics in schizophrenia: pilot study | Abstract similar documents |
| T. V. Zhilyaeva, D. S. Shvachkina, A. S. Piatoikina, E. S. Zhukova, O. V. Kostina, T. G. Shcherbatyuk, G. E. Mazo | ||
| "... Antipsychotics (AP) administration in schizophrenia patients is associated with several side ..." | ||
| Vol 14, No 1 (2022) | Drug-induced liver injury with cholestasis in the neurologist and psychiatric practice | Abstract PDF (Eng) similar documents |
| O. D. Ostroumova, E. V. Shikh, N. V. Shikh, T. M. Ostroumova, Y. A. Isaakyan | ||
| "... : paroxetine, sertraline, fluoxetine, citalopram, escitalopram), antidepressants), antipsychotics ..." | ||
| Vol 14, No 2 (2022) | Treatment of mental disorders of generative cycle in women | Abstract similar documents |
| V. E. Medvedev | ||
| "... , anxiolytics, antipsychotics with an emphasis on good tolerance, a minimum of adverse events, compatibility ..." | ||
| Vol 12, No 6 (2020) | Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes | Abstract similar documents |
| D. V. Ivashchenko, A. S. Osipov, E. V. Nazarova, M. A. Ovchinnikova, N. I. Buromskaya, V. V. Smirnov, P. V. Shimanov, R. V. Deitch, T. A. Fainshtein, E. N. Shagovenko, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Yu. S. Shevchenko, D. A. Sychev | ||
| "... Antipsychotics are a first-line treatment for psychotic disorders. The cytochrome P450 isoenzymes ..." | ||
| Vol 4, No 4 (2012) | 60 th anniversary of the design of antipsychotics (on their classification) | Abstract similar documents |
| Dmitry Sergeyevich Danilov | ||
| "... The paper describes the most important periods in the history of the design of antipsychotics ..." | ||
| Vol 13, No 6 (2021) | Drug-induced parkinsonism | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, O. D. Ostroumova, A. S. Soloveva | ||
| "... commonly associated with antipsychotic drugs, monoamine reuptake inhibitors, and calcium channel blockers ..." | ||
| Vol 12, No 1 (2020) | Drug-induced tardive dyskinesia | Abstract similar documents |
| T. M. Ostroumova, V. A. Tolmacheva, O. D. Ostroumova, V. A. Parfenov | ||
| "... taking metoclopramide, antipsychotics, antidepressants, calcium channel blockers, and other drugs ..." | ||
| Vol 14, No 3 (2022) | Neuropsychiatric disorders correction in Alzheimer's disease | Abstract similar documents |
| N. N. Koberskaya | ||
| "... . Antipsychotics are often associated with serious side effects and increased mortality in patients with dementia ..." | ||
| Vol 4, No 1 (2012) | Sleep disorders in mental diseases and their correction | Abstract similar documents |
| Nina Arkadyevna Tyuvina, E P Shchukina, E A Izotova | ||
| "... of sanval both alone and in combination with other psychotropic drugs (antidepressants and antipsychotics ..." | ||
| Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Neurocognitive deficit in patients with schizophrenia | Abstract similar documents |
| A. B. Shmukler, I. Ya. Gurovich, Yu. S. Zaitseva | ||
| "... antipsychotics on the time course of changes in neurocognitive impairments in patients with the first psychotic ..." | ||
| Vol 13, No 2 (2021) | Drug-induced hypersomnia | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, O. D. Ostroumova, A. V. Filippova, T. F. Guseva | ||
| "... . Most often, the development of DIH is associated with the use of levodopa-carbidopa, antipsychotics ..." | ||
| Vol 17, No 2 (2025) | Drug-induced dyskinesia when taking Fluvoxamine | Abstract similar documents |
| A. A. Katok, D. M. Khasanova, I. A. Khasanov | ||
| "... of antidepressants and antipsychotics prescribed and an increasing awareness of possible side effects. Fluvoxamine ..." | ||
| Vol 13, No 6 (2021) | Treatment of noncognitive neuropsychiatric disorders in Alzheimer's disease | Abstract similar documents |
| A. B. Lokshina, D. A. Grishina | ||
| "... for antipsychotic administration in this disease, NСNPDs treatment in AD, which includes nonpharmacological ..." | ||
| Vol 14, No 1 (2022) | Comparative evaluation of psychopharmacotherapy of atypical depression in bipolar and recurrent affective disorder, psychogenic depression | Abstract PDF (Eng) similar documents |
| M. S. Verbitskaya, N. A. Tyuvina, Yu. G. Tyulpin, G. L. Krenkel | ||
| "... , or a combination of AD and antipsychotic (A), AD and A, MS and A, as well as a combination of AD, A and MS ..." | ||
| Vol 12, No 3 (2020) | Drug-induced cognitive impairment | Abstract similar documents |
| O. D. Ostroumova, M. I. Kulikova, T. M. Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, V. A. Parfenov | ||
| "... Many classes of medications, such as antipsychotics, anticonvulsants, anticholinergics, and other ..." | ||
| Vol 12, No 4 (2020) | Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, I. A. Shchukin | ||
| "... , including antiepileptic drugs (n=20), dopaminergic agents (n=19), antipsychotics (n=38), anxiolytics (n=21 ..." | ||
| Vol 6, No 3 (2014) | Alcohol abuse and related disorders treatment of alcohol dependence | Abstract similar documents |
| Yu. P. Sivolap | ||
| "... in using antipsychotics to suppress a craving for alcohol (as well as other psychoactive substances ..." | ||
| Vol 12, No 2 (2020) | Investigation of the efficiency of various antidepressant replacement regimens in the development of SSRI-induced apathy syndrome | Abstract similar documents |
| V. E. Medvedev, R. A. Kardashyan, V. I. Frolova, A. M. Burno, S. V. Nekrasova, V. I. Salyntsev | ||
| "... thymoleptic effect, including when combined with the antipsychotic sulpiride (50 mg/day). ..." | ||
| Vol 10, No 1 (2018) | Cognitive impairment in anxiety disorders | Abstract similar documents |
| B. A. Volel, D. S. Petelin, R. V. Akhapkin, A. A. Malyutina | ||
| "... frequently used drugs (antidepressants, atypical antipsychotics, anticonvulsants, tranquilizers) does ..." | ||
| Vol 13, No 5 (2021) | Alcohol-Induced Psychotic Disorder and Depressive Disorder: a Dual Diagnosis Case Series | Abstract PDF (Eng) similar documents |
| A. Elbelushi, Z. Muravec, H. Masood, B. Masood | ||
| "... (SAPAS) and Modified Sainsbury Tool. Antidepressants and antipsychotics were chosen based on drug ..." | ||
| Vol 13, No 3 (2021) | Depression treatment in women and men with bipolar affective disorder: a comparative study | Abstract similar documents |
| N. A. Tyuvina, A. E. Stolyarova, V. V. Balabanova, K. M. Bunkova, E. N. Efremova | ||
| "... , antipsychotics combinations were used to treat depression. We performed a comparative analysis of treatment ..." | ||
| Vol 15, No 4 (2023) | Comorbid disorders and therapy of persistent postural perceptual dizziness | Abstract similar documents |
| E. N. Zastenskaya, L. M. Antonenko | ||
| "... .80 to 29.6±12.80 points (p<0.001), in the group with PPPD and peripheral vestibular disorders – from 49 ..." | ||
| Vol 4, No 1 (2012) | Experience in using sulpiride in non-psychotic endogenous depressive-hypochondriacal disorders | Abstract similar documents |
| Nina Arkadyevna Tyuvina, V. V. Balabanova, E M Goncharova | ||
| "... in depressive-hypochondriacal syndrome and to its antipsychotic and activating activities in SPS. ..." | ||
| Vol 15, No 4 (2023) | Psychosocial factors and sleep disorders in the population aged 25–64 years in Russia/Siberia (International WHO MONICA-Psychosocial Programme) | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. V. Gafarova | ||
| "... of: anxiety (HLA) in 61.8% of men (χ2=56.169; df=4; p<0.001) and 68.1% of women (χ2=36.535; df=4; p<0.001 ..." | ||
| Vol 15, No 2 (2023) | Quality of life of patients with rheumatoid arthritis and comorbid fibromyalgia | Abstract similar documents |
| N. A. Melikova, E. S. Filatova, E. G. Filatova, A. M. Lila | ||
| "... at rest was 7 and 4 cm (p<0.001), the average score on the CSI questionnaire was 50 and 38.5 (p<0.001 ..." | ||
| Vol 13, No 3 (2021) | Validation of a Russian version of the Berg Balance Scale | Abstract similar documents |
| N. A. Suponeva, D. G. Yusupova, A. A. Zimin, A. B. Zaitsev, K. A. Yatsko, D. A. Melchenko, A. A. Rimkevichus, E. S. Zhirova, A. S. Taratukhina, A. S. Rizvanova, G. A. Gatina, M. E. Kalinkina, M. A. Piradov, K. Berg | ||
| "... points), reliability (Pearson's correlation coefficient r=0.98, р<0.0001; Cronbach's alpha α=0.94 р<0.001 ..." | ||
| Vol 14, No 4 (2022) | Smoking and sleep disorders (population-based study under the WHO “MONICA-psychosocial” program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelgorn, A. V. Gafarova | ||
| "... – 12.2%) and 78.6% of women (satisfactory sleep – 58.9%, poor sleep – 19.7%; χ2 =38.553; df=2; p<0.001 ..." | ||
| Vol 15, No 6 (2023) | NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study | Abstract similar documents |
| A. B. Danilov, A. A. Pilipovich, M. V. Pyastolova | ||
| "... on the VAS before treatment versus 10 [0; 20] after treatment; p<0.0001) and normalisation of sleep in most ..." | ||
| Vol 13, No 5 (2021) | Awareness of cardiovascular diseases risk factors, attitude towards their health and sleep disorders among the 25–64 years old population in Russia/Siberia (WHO International «MONICA-psychosocial» program) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelhorn, A. V. Gafarova | ||
| "... that they were «not entirely healthy» (men – 65.5%, χ2 =57.825, df=8, p<0.001 and women – 69.6%, χ2 =96.883, df=4 ..." | ||
| Vol 12, No 6 (2020) | Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke | Abstract PDF (Eng) similar documents |
| S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, К. V. Sobyanin | ||
| "... .7 [30.5; 39.9] ml/m2 vs 28.5 [25.6; 34.6] ml/m2 vs 27.1 [24.5; 31.2] ml/m2 ; p< 0.001) and NT-proBNP ..." | ||
| Vol 15, No 6 (2023) | Chronic dizziness: modern treatment methods taking into account comorbidity | Abstract similar documents |
| E. N. Zastenskaia, L. M. Antonenko | ||
| "... decreased from 45.59±15.47 to 29.9±12.56 points (p<0.001), the severity of anxiety according to BAI from 27 ..." | ||
| Vol 13, No 4 (2021) | Fatigue and cognitive impairment in post-COVID syndrome: possible treatment approaches | Abstract similar documents |
| A. N. Bogolepova, N. A. Osinovskaya, E. A. Kovalenko, E. V. Makhnovich | ||
| "... completely (in 42% of participants) or became subclinical (in 48%; р<0.001). CI severity also reduced ..." | ||
| Vol 10, No 4 (2018) | Research Institute of Internal and Preventive Medicine, Branch, Federal Research Center, Institute of Cytology and Genetics, Siberian Branch, Russian Academy of Sciences | Abstract similar documents |
| A. V. Titarenko, S. V. Shishkin, L. V. Shcherbakova, E. G. Verevkin, M. Holmes, M. Bobak, S. K. Malyutina | ||
| "... groups, which was steeper in women than in men (p<0.001). Persons aged 70 years and older showed negative ..." | ||
| Vol 8, No 1 (2016) | Changes in spastic muscles of patients with infantile cerebral palsy according to ultrasound findings | Abstract similar documents |
| S. V. Vlasenko, G. M. Kushnir, T. F. Golubeva, E. A. Osmanov, E. V. Strashko | ||
| "... ), and age at contracture formation (R=0.60; p=0.001). Analysis of USG and electromyographic findings ..." | ||
| Vol 12, No 6 (2020) | Cognitive and emotional impairment in patients with migraine and signs of leukoencephalopathy during preventive therapy | Abstract similar documents |
| K. A. Pozhidaev, V. A. Parfenov | ||
| "... scores of the MoCA (p=0.004), the 12- word recall test (p=0.0003), and the tests of literal (p=0.001 ..." | ||
| Vol 11, No 1 (2019) | Role of the intact hemisphere in determining the rehabilitation potential in the acute period of ischemic stroke: a diffusion and perfusion model | Abstract similar documents |
| N. A. Kaileva, A. A. Kulesh, N. Kh. Gorst, A. Yu. Bykova, V. E. Drobakha, K. V. Sobyanin, I. N. Shardakov, V. V. Shestakov | ||
| "... NIHSS value (r = 0.55; p < 0.001), the size of a focus (r = 0.42; p < 0.001), FA in the contralateral ..." | ||
| Vol 11, No 1 (2019) | Social support and stroke risk: an epidemiological study of a population aged 25–64 years in Russia/Siberia (the WHO MONICA-psychosocial program) | Abstract PDF (Eng) similar documents |
| A. V. Gafarova, E. A. Gromova, D. О. Panov, I. V. Gagulin, E. A. Krymov, V. V. Gafarov | ||
| "... .8% of women (χ2=22.603; df=2; p=0.0001) and a low SNI in 43.5% of men and in 33.9% of women (χ2=21.546; df=2 ..." | ||
| Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
| E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
| "... .05-0.001). There were statistically significant differences in the measures of short-term (5.9±0 ..." | ||
| Vol 7, No 1 (2015) | Vascular cognitive impairments in chronic kidney disease | Abstract similar documents |
| I. V. Rogova, V. V. Fomin, I. V. Damulin, E. G. Minakova, O. Yu. Selivanova, Yu. A. Petleva | ||
| "... –IV than in those with Stages I–II, as shown by the scores of the mini-mental state examination (p<0.001 ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... was decreased in patients in group 2 (p<0.001), asymmetry of the indicator was noted, in several patients ..." | ||
| Vol 16, No 3 (2024) | Fremanezumab in real-life clinical practice: specialized headache center experience | Abstract similar documents |
| Yu. E. Azimova, K. V. Skorobogatikh, V. V. Osipova, D. Z. Korobkova, N. V. Vashchenko, E. Z. Mamkhegov, A. S. Galanina, E. A. Guziy | ||
| "... .2 (before treatment) to 8.5±7.9 after 12 weeks (p<0.0001), in the EM group from 10.9±4.1 to 3.6±3.7 (p<0.0001 ..." | ||
| Vol 13, No 3 (2021) | Sleep disorder trends in 1988–2018 among the 25–64 years old population in Russia/Siberia (WHO MONICA Psychosocial study) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, I. V. Gagulin, A. N. Tripelgorn, A. V. Gafarova | ||
| "... (χ2 =122.061; υ=16; p<0.001 – men; χ2 =230.626; υ=16; p<0.001 – women). In 1988–2018 there was a 2 ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... from 19.8 to 23.3 points (p≥0.001) was observed in the omberacetam group. In other groups, an increase ..." | ||
| Vol 14, No 3 (2022) | The impact of non-motor disorders on the quality of life of patients with cervical muscular dystonia | Abstract similar documents |
| M. R. Nodel, N. I. Salouhina, V. A. Tolmacheva | ||
| "... <0.001 ), moderate strength correlation – with indicators of anxiety (r=0.65; p<0 ..." | ||
| Vol 14, No 3 (2022) | Comorbidities and therapy for chronic non-specific low back pain and fibromyalgia | Abstract similar documents |
| T. I. Nasonova, E. V. Parfenova | ||
| "... ; p<0.001), sleepiness according to ESS (8.2±4.6 and 6.2±4.6 points; p=0.014), somatization according ..." | ||
| Vol 15, No 3 (2023) | Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder | Abstract similar documents |
| Ju. E. Azimova, Yu. P. Sivolap, K. A. Ishchenko | ||
| "... .27 (p<0.0001). The proportion of patients with a decrease in the total score on the HARS scale by 50 ..." | ||
| Vol 16, No 4 (2024) | Kinesiotherapy in painful diabetic polyneuropathy | Abstract similar documents |
| E. V. Mandra, V. A. Parfenov, L. T. Akhmedzhanova, E. S. Shulakova, V. V. Fadeev, M. V. Amosova | ||
| "... .80 ± 1.06 points respectively after 6 months (p < 0.001), reduction in neuropathic pain according to NTSS ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Demographic and comorbid factors associated with the development of medication overuse headache | Abstract similar documents |
| Ia. A. Kniazeva, D. V. Gilev, V. V. Osipova, E. R. Lebedeva | ||
| "... occurred more frequently in the MOH group (53 and 16%, respectively; p<0.001; OR 5.9; 95% CI 3.6–9.8). One ..." | ||
| Vol 16, No 6 (2024) | Antidepressant and anxiolytic efficacy and tolerability of agomelatine in the treatment of depression after COVID-19 in daily clinical practice (non-interventional study TELESPHOR) | Abstract similar documents |
| V. E. Medvedev, A. N. Bogolepova, D. P. Morozov, B. B. Kvasnikov | ||
| "... .6 points – by 2.6±3.3, 6.7±5.3 and 10.9±4.9 points, respectively, compared to baseline (p<0.0001 for all ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... , USA). Results and discussion. We found a significant (p<0.001) decrease in the thickness ..." | ||
| Vol 14, No 3 (2022) | Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation | Abstract similar documents |
| O. D. Ostroumova, T. M. Ostroumova | ||
| "... compared to warfarin (p<0.0001), including a 51% greater hemorrhagic stroke (HS) risk reduction (p<0.0001 ..." | ||
| Vol 14, No 4 (2022) | Anxiety-depressive spectrum disorders in cervical dystonia | Abstract similar documents |
| V. A. Tolmacheva, P. G. Yuzbashyan, D. S. Petelin, B. A. Volel, N. I. Salouhina, M. R. Nodel, D. V. Romanov | ||
| "... with the control group (p<0.001). Anxiety symptoms show a significant dependence on the clinical severity of CD ..." | ||
| Vol 10, No 4 (2018) | Impact of stimulating cognitive-motor training on neuropsychological status and quality of life in patients with Parkinson's disease | Abstract similar documents |
| Yu. N. Bykov, T. B. Bender, Yu. N. Vasiliev, A. N. Kalyagin, Т. М. Maksikova, G. M. Orlova, N. M. Kozlova, O. V. Ryzhkova | ||
| "... for the following domains: physical functioning (p<0.01), role-physical functioning (p<0.001), pain intensity (p<0 ..." | ||
| Vol 12, No 5 (2020) | The use of vortioxetine for depression in patients with Parkinson's disease in the early and advanced stages of the disease | Abstract similar documents |
| I. V. Miliukhina | ||
| "... and anxiety (p < 0.001). Vortioxetine demonstrated an optimal balance between tolerability and clinical ..." | ||
| Online-first | Association of carriers of single nucleotide polymorphisms rs1143634 and rs16944 in gene Il-1B and rs6265 in gene BDNF with temporal lobe epilepsy | Abstract similar documents |
| Y. S. Panina, D. V. Dmitrenko, N. A. Shnayder, E. V. Egorova, A. A. Usoltseva | ||
| "... % CI: 1.31-3.08; p = 0.001) and the homozygous genotype CC (OR = 2.48; 95% CI: 1.47-4.17; p = 0.001 ..." | ||
| Vol 9, No 4 (2017) | Membrane characteristics and vascular cognitive impairment | Abstract PDF (Eng) similar documents |
| Yu. V. Zhitkova, D. R. Khasanova, V. N. Oslopov | ||
| "... predominance of not only the total number of dementias (86.7% of the patients in IV quartile; p<0.001 ..." | ||
| Vol 10, No 1 (2018) | Possibilities of contrast-free magnetic resonance perfusion imaging for the detection of early brain damage in essential hypertension | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, V. A. Parfenov, O. D. Ostroumova, E. M. Perepelova, V. A. Perepelov, E. V. Borisova | ||
| "... regions was significantly (p < 0.001) lower than that in the controls: right CBF, 39.1±5.6 and 45.8±3.2 ml ..." | ||
| Vol 9, No 1S (2017): SPECIAL ISSUE: EPILEPSY | Analysis of the clinical experience with perampanel in the Moscow Region: Efficacy, tolerability, individual choice priorities | Abstract similar documents |
| I. G. Rudakova, Yu. A. Belova | ||
| "... %, respectively; p = 0.0001), but those with temporal lobe epilepsy and isolated regional EEG patterns were 2–3 ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... . The latency of the P100 wave increased dramatically and differed significantly (p<0.001) from those ..." | ||
| Vol 2, No 4 (2010) | Novelty in the treatment of episodic tension-type headache | Abstract similar documents |
| G. R. Tabeeva, Yu. E. Azimova | ||
| "... .085). The efficacy predictors were less pain intensity (p < 0.001) and a shorter time after onset (p < 0.001 ..." | ||
| 1 - 70 of 128 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
